Rhodiola and ashwagandha: Which adaptogens have real data

The category problem

“Adaptogen” is a marketing category more than a pharmacological one. The term was coined by Soviet pharmacologist Nikolai Lazarev in 1947 to describe substances that increase nonspecific resistance to stress. It is not an FDA-recognized classification. Any supplement brand can call any botanical an adaptogen and typically does.

The wellness industry has expanded the category to include dozens of herbs with little or no human clinical evidence, bundled them into expensive stacks, and positioned them as the solution to modern burnout. Most of them are marketing. A few are not. The distinction matters because they are not cheap and the placebo effect in this category is strong.

Rhodiola rosea: The evidence

Rhodiola rosea has more published randomized controlled trials than any other adaptogen. The most-cited mechanisms: inhibition of monoamine oxidase (MAO), which slows the breakdown of dopamine and serotonin; activation of opioid peptides that modulate the stress response; and effects on cortisol via interactions with the hypothalamic-pituitary-adrenal axis.

A 2012 randomized controlled trial in adults experiencing stress, published in Phytomedicine, found significant improvements in fatigue, exhaustion, and cognitive function after 28 days of rhodiola extract compared with placebo. A 2009 Swedish study of night-shift physicians found improved cognitive performance and reduced fatigue during periods of stress with 170 mg of rhodiola extract. A 2017 Cochrane-adjacent systematic review found positive effects on mental fatigue and physical endurance but noted that the quality of the evidence across studies was moderate at best.

The caveat: rhodiola research is dominated by small trials, inconsistent standardization of the extract, and manufacturer funding. The effect sizes are real but modest. Rhodiola is not a substitute for sleep. What it does is reduce the performance impairment of acute cognitive stress, which is a specific and useful claim.

Effective dose: 200 to 600 mg daily of a standardized extract containing 3 percent rosavins and 1 percent salidroside. Taken in the morning; mild stimulatory effect means evening dosing can disrupt sleep. Standardized rhodiola rosea extract is available as a single-ingredient supplement; avoid proprietary blends where the rhodiola dose is not disclosed.

Ashwagandha: The evidence

Ashwagandha (Withania somnifera) is the most researched adaptogen for cortisol and stress. The strongest evidence is for the KSM-66 extract, a full-spectrum root extract with 5 percent withanolides, which has the best standardization and the most clinical backing of any ashwagandha form.

A 2012 randomized, double-blind, placebo-controlled trial in chronically stressed adults (Chandrasekhar et al., Indian Journal of Psychological Medicine) found that KSM-66 at 300 mg twice daily reduced serum cortisol by 27.9 percent, reduced perceived stress scores by 44 percent, and significantly improved general well-being scores compared to placebo after 60 days. A 2019 study found KSM-66 at 300 mg twice daily improved sleep quality and morning alertness in adults with insomnia. A 2015 study found improvements in cardiorespiratory endurance in healthy adults.

The mechanism is primarily through the HPA axis: withanolides appear to modulate cortisol secretion and reduce the stress-driven elevation in cortisol that depletes energy. This is not stimulant-like. The energy-boosting effect of ashwagandha takes two to four weeks to manifest and works by removing a brake (excess cortisol) rather than by stepping on the accelerator. KSM-66 ashwagandha 300 mg is the specific form with the clinical backing. Generic ashwagandha root powder without standardization is not equivalent.

What does not earn its place

Maca. Libido and subjective energy improvements in some small trials. No convincing evidence for cortisol, cognitive performance, or objective fatigue. The effect may be real; the mechanism is unclear, and the data are thin.

Eleuthero (Siberian ginseng). Part of the original Soviet research on adaptogens. Most of that research was conducted with poor methodology. Modern trials are small and inconsistent. Not enough to recommend.

Lion’s mane for fatigue. The cognitive and nerve growth factor (NGF) evidence for lion’s mane is interesting. The evidence for lion’s mane as a fatigue or energy intervention is thin. It is two separate claims; the one with data is cognition, not energy.

Multi-adaptogen blends. When you cannot verify the dose of any individual ingredient, you cannot evaluate whether any individual ingredient is at an effective dose. Most multi-adaptogen stacks have proprietary blends with undisclosed individual doses. They are sold on category marketing, not on the specific evidence.

The Livium recipe

Tool. Pick one, not both, to start. If fatigue is primarily stress-driven and cortisol-related (worst energy during high-stress periods, poor sleep, feeling wired but tired): start with KSM-66 ashwagandha 300 mg twice daily. Give it 8 weeks. If fatigue is primarily cognitive and performance-related (worst energy during sustained mental work, moderate stress, generally adequate sleep): start with rhodiola rosea 400 mg standardized extract in the morning. Give it 4 weeks.

Behavior. The most common reason adaptogens underdeliver is that the underlying cause of fatigue is not cortisol dysregulation but rather something else: low ferritin, suboptimal thyroid function, sleep apnea, or declining testosterone or estrogen levels. Run bloodwork before spending money on adaptogens. Function Health covers the full panel. If the bloodwork is clean and cortisol rhythm is the suspect, then adaptogens are a reasonable tool. If the bloodwork reveals a deficiency, fix the deficiency first. Adaptogens on top of untreated iron deficiency or low T3 are a waste of money.

Threshold. 8 weeks of consistent use is the minimum evaluation period for ashwagandha. 4 weeks for rhodiola. If there is no subjective improvement after that window, the underlying cause of your fatigue is not in this category. Stop and look upstream. Adaptogens are not a permanent patch; they are a tool for a specific cause of fatigue, backed by decent evidence.

Source: NIH Office of Dietary Supplements and Chandrasekhar et al., Indian Journal of Psychological Medicine (2012) KSM-66 RCT.

Plan of action

• Run bloodwork before buying adaptogens. Ferritin, TSH, free T3, testosterone or estradiol, vitamin D, and vitamin B12 should all be within optimal ranges before assuming your fatigue is an adaptation problem. Function Health covers the full panel in one draw.
• If bloodwork is clean and fatigue is stress-related: try KSM-66 ashwagandha 300 mg morning and evening for 8 weeks. Keep everything else consistent so you can isolate the effect. The benefit is not dramatic; it is a gradual reduction in stress-driven exhaustion that feels normal until it is not.
• If fatigue is cognitive and performance-focused rather than stress-driven: try rhodiola rosea 400 mg standardized extract in the morning for 4 weeks. Time it to your highest-cognitive-demand periods.
• Avoid proprietary adaptogen blends. Buy single-ingredient supplements with disclosed standardization. If the label does not state the percentage of active compounds (e.g., rosavins in rhodiola, withanolides in ashwagandha), the product is not reliably dosed.